Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats

NeuroToxicology

Volumn 33, Issue 5, 2012, Pages 1265-1275

  Menze, Esther T ^a   Tadros, Mariane G ^a   Abdel Tawab, Ahmed M ^a   Khalifa, Amani E ^a  

^a Ain Shams University   (Egypt)

Author keywords

3 Nitropropionic acid; Hesperidin; Huntington; Inducible nitric oxide; Prepulse inhibition

Indexed keywords

3 NITROPROPIONIC ACID; CATALASE; HESPERIDIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; EDEMA; ELECTRON MICROSCOPY; HIPPOCAMPUS; HISTOPATHOLOGY; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MITOCHONDRION SWELLING; MOTOR DYSFUNCTION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STARTLE REFLEX; ULTRASTRUCTURE;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CATALASE; CONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HESPERIDIN; INHIBITION (PSYCHOLOGY); LIPID PEROXIDATION; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; NITRIC OXIDE SYNTHASE TYPE II; NITRO COMPOUNDS; PROPIONATES; RATS; RATS, WISTAR; STARTLE REACTION; TIME FACTORS;

PRIMATES; RATTUS;

EID: 84867231608     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.07.007     Document Type: Article

References (45)

1. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
2. Ahuja M., Bishnoi M., Chopra K. Protective effect of minocycline, a semi-synthetic-second generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicology 2008, 244:111-122.
3. AlMutairy A., Al Kadasah S., Elfaki I., Arshaduddin M., Malik D., Al Moutaery K., et al. Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats. Neurotoxicol Teratol 2010, 32:226-233.
4. Alston T.A., Mela L., Bright H.J. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci U S A 1977, 74:3767-3771.
5. Balakrishnan A., Menon V.P. Effect of hesperidin on matrix metalloproteinases and antioxidant status during nicotine-induced toxicity. Toxicology 2007, 238:90-98.
6. Bayram-Weston Z., Jones L., Dunnett S.B., Brooks S.P. Light and electron microscopic characterization of the evolution of cellular pathology in the R6/1 Huntington's disease transgenic mice. Brain Res Bull 2012, 88:104-112.
7. Q92 Huntington's disease knock-in-mice. Brain Res Bull 2012, 88:171-181.
8. Beal M.F. Mitochondrial dysfunction in neurodegenerative disease. Biochem Biophys Acta 1998, 1366:211-223.
9. Beal M.F., Broulillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993, 13:4181-4192.
10. Bozzola J.J., Russell L.D. Electron microscopy principles and techniques for biologists 1991, Jones and Bartlett Boston.
11. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: human and animal studies. Arch Gen Psychiatry 1990, 47:181-188.
12. Buuse M.V., Eikelis N. Estrogen increases prepulse inhibition of acoustic startle in rats. Eur J Pharmacol 2001, 425:33-41.
13. Colle D., Hartwig J.M., Antunes Soares F.A., Farina M. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro. Brain Res Bull 2012, 87:397-405.
14. Curzon P., Zhang M., Radek R.J., Fox J.B. Assessment of sensorimotor processes in the mouse: sensory gating, locomotor activity, rotarod and beam walking. Methods of behavior analysis in neuroscience. 2009, CRC press, Boca Raton, FL. J.J. Buccafusco (Ed.).
15. Deshpande S.B., Hida H., Takei lo N., Masuda T., Baba H., Nishino H. Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats. Brain Res 2006, 1108:205-215.
16. Gaur V., Aggarwal A., Kumar A. Possible nitric oxide mechanism in the protective effect of hesperidin against ischemic reperfusion cerebral injury in rats. Ind J Exp Biol 2011, 49:609-618.
17. Hamilton B.F., Gould D.H. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol 1987, 72:286-297.
18. Johansson A.C., Hegardt P., Janelidze S., Visse E., Widegren B., Siesjö P. Enhanced expression of iNOS intratumorally and at the immunization site after immunization with IFNγ-secreting rat glioma cells. J Neuroimmunol 2002, 123:135-143.
19. Kamaraj S., Anandakumar P., Jagan S., Ramakrishnan G., Devaki T. Hesperidin attenuates mitochondrial dysfunction during benzo(a)pyrene-induced lung carcinogenesis in mice. Fundam Clin Pharmacol 2011, 1:91-98.
20. Kodsi M.H., Swerdlow N.R. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease. Neurosci Lett 1997, 231:103-107.
21. Koppal T., Drake J., Yatin S., Jordan B., Varadarjan S., Bettenhausen L., et al. Peroxynitrite-induced alteration in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J Neurochem 1999, 72:310-317.
22. Koutouzis T.K., Emerich D., Borlongan C.V., Freeman T.B., Cahill D.W., Sanberg P.R. Cell transplantation for central nervous system disorders. CRC Crit Rev Clin Neurobiol 1994, 3:25-162.
23. Kumar P., Padi S.S., Naidu P.S., Kumar A. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity. Methods Find Exp Clin Pharmacol 2007, 29:1-7.
24. Kumar P., Kumar A. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunction in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:100-108.
25. Kumar P., Kumar A. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid-induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food Chem Toxicol 2009, 47:2522-2530.
26. Kumar P., Kumar A. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav Brain Res 2010, 6107:1-9.
27. Ludolph C.A., He F., Spencer P.S., Hammerstad J., Sabri M. 3-Nitropropionic acid: exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 1991, 18:492-498.
28. Mahdy H.M., Tadros M.G., Mohamed M.R., Karim A.M., Khalifa A.E. The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats. Neurochem Int 2011, 59:770-778.
29. Mu S., OuYang L., Liu B., Zhu Y., Li K., Zhan M., et al. Protective effect of melatonin on 3-NP induced striatal interneuron injury in rats. Neurochem int 2011, 59:224-234.
30. Nishino H., Shimano Y., Kumazaki M., Sakurai T. Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood brain barrier. Neurosci Lett 1995, 186:161-164.
31. Nishino H., Fujimoto I., Shimano Y., Hida H., Kumazaki M., Fukuda A. 3-Nitropropionic acid produces striatum selective lesions accompanied by iNOS expression. J Chem Neuroanat 1996, 10:209-212.
32. Pavese N., Gerhard A., Tai Y.F., Ho A.K., Turkheimer F., Barker R.A. Microglial activation correlates with severity in Huntington's disease: a clinical and PET study. Neurology 2006, 66:1638-1643.
33. Raso G.M., Meli R., Di Carlo G., Pacilio M., Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2-expression by flavonoids in macrophage J774A.1. Life Sci 2001, 68:921-931.
34. Raza S.S., Khan M.M., Ahmad A., Ashafaq M., Khuwaja G., Tabassum R., et al. Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke. Brain Res 2011, 1420:93-105.
35. Rosenstock T.R., Abilio V.C., Frussa-Filho R., Kiyomota B.H., Smaila S.S. Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid. Pharmacol Biochem Behav 2009, 91:327-332.
36. Ryu J.K., Nagai A., Kim J., Lee M.C., McLarnon J.G., Kim S.U. Microglial activation and cell death induced by the mitochondrial toxin 3-nitropropionic acid: in vitro and in vivo studies. Neurobiol Dis 2003, 12:121-132.
37. Sakata K., Hirose Y., Qiao Z., Tanaka T., Mori H. Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line. Cancer Lett 2003, 199:139-145.
38. Schulz J.B., Henshaw D.R., Macgarvey U., Beal M.F. Involvement of oxidative stress in 3-NP neurotoxicity. Neurochem Int 1996, 29:167-171.
39. Seaman R.L. Effects of acute systemic 3-nitropropionic acid administration on rat activity and acoustic startle. Neurosci Lett 2000, 280:183-186.
40. Swerdlow N.R., Paulsen J., Braff D.L., Butters N., Geyer M.A., Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 1995, 58:192-200.
41. Tadros M.G., Khalifa A.E., Abdel-Naim A.B., Arafa H.M. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype. Pharmacol Biochem Behav 2005, 82:574-582.
42. Tunez I., Tasset I., Perez-De La Cruz V., Santamaria A. 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. Molecules 2010, 15:878-916.
43. Uchiyama M., Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978, 86:271-278.
44. Vaughan G.J., Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999, 30:1969-1973.
45. Yuan G., Zhou X., Gong Z., Zhang P., Sun X., Zheng S. Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury. World J Gastroenterol 2006, 12:2375-2381.